Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on September 12, 2002; DOI 10.1182/blood-2002-05-1549.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-05-1549v1
101/2/498    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cao, Z.
Right arrow Articles by Roberts, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cao, Z.
Right arrow Articles by Roberts, A. B.
Related Collections
Right arrow Signal Transduction
Right arrow Hematopoiesis and Stem Cells
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 15 January 2003, Vol. 101, No. 2, pp. 498-507

HEMATOPOIESIS

Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-beta and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells

Zhouhong Cao, Kathleen C. Flanders, Daniel Bertolette, Lyudmila A. Lyakh, Jens U. Wurthner, W. Tony Parks, John J. Letterio, Francis W. Ruscetti, and Anita B. Roberts

From the Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, Bethesda, MD, and the Basic Research Laboratory, National Cancer Institute (NCI)-Frederick, Frederick, MD.

We have investigated the role of Smad family proteins, known to be important cytoplasmic mediators of signals from the transforming growth factor-beta (TGF-beta ) receptor serine/threonine kinases, in TGF-beta -dependent differentiation of hematopoietic cells, using as a model the human promyelocytic leukemia cell line, HL-60. TGF-beta -dependent differentiation of these cells to monocytes, but not retinoic acid-dependent differentiation to granulocytes, was accompanied by rapid phosphorylation and nuclear translocation of Smad2 and Smad3. Vitamin D3 also induced phosphorylation of Smad2/3 and monocytic differentiation; however the effects were indirect, dependent on its ability to induce expression of TGF-beta 1. Simultaneous treatment of these cells with TGF-beta 1 and all-trans-retinoic acid (ATRA), which leads to almost equal numbers of granulocytes and monocytes, significantly reduced the level of phospho-Smad2/3 and its nuclear accumulation, compared with that in cells treated with TGF-beta 1 alone. TGF-beta 1 and ATRA activate P42/44 mitogen-activated protein (MAP) kinase with nearly identical kinetics, ruling out its involvement in these effects on Smad phosphorylation. Addition of the inhibitor-of-protein serine/threonine phosphatases, okadaic acid, blocks the ATRA-mediated reduction in TGF-beta -induced phospho-Smad2 and shifts the differentiation toward monocytic end points. In HL-60R mutant cells, which harbor a defective retinoic acid receptor-alpha (RAR-alpha ), ATRA is unable to reduce levels of TGF-beta -induced phospho-Smad2/3, coincident with its inability to differentiate these cells along granulocytic pathways. Together, these data suggest a new level of cross-talk between ATRA and TGF-beta , whereby a putative RAR-alpha -dependent phosphatase activity limits the levels of phospho-Smad2/3 induced by TGF-beta , ultimately reducing the levels of nuclear Smad complexes mediating the TGF-beta -dependent differentiation of the cells to monocytic end points.

© 2003 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
H. Kawajiri, M. Yashiro, O. Shinto, K. Nakamura, M. Tendo, S. Takemura, M. Node, Y. Hamashima, T. Kajimoto, T. Sawada, et al.
A Novel Transforming Growth Factor {beta} Receptor Kinase Inhibitor, A-77, Prevents the Peritoneal Dissemination of Scirrhous Gastric Carcinoma
Clin. Cancer Res., May 1, 2008; 14(9): 2850 - 2860.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Y. Ji, H. J. Lee, C. Goodman, M. Uskokovic, K. Liby, M. Sporn, and N. Suh
The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells.
Mol. Cancer Ther., June 1, 2006; 5(6): 1452 - 1458.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. J. Lee, A. Wislocki, C. Goodman, Y. Ji, R. Ge, H. Maehr, M. Uskokovic, M. Reiss, and N. Suh
A Novel Vitamin D Derivative Activates Bone Morphogenetic Protein Signaling in MCF10 Breast Epithelial Cells
Mol. Pharmacol., June 1, 2006; 69(6): 1840 - 1848.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
N. Urahama, M. Ito, A. Sada, K. Yakushijin, K. Yamamoto, A. Okamura, K. Minagawa, A. Hato, K. Chihara, R. G. Roeder, et al.
The role of transcriptional coactivator TRAP220 in myelomonocytic differentiation
Genes Cells, December 1, 2005; 10(12): 1127 - 1137.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. A. Lyakh, M. Sanford, S. Chekol, H. A. Young, and A. B. Roberts
TGF-{beta} and Vitamin D3 Utilize Distinct Pathways to Suppress IL-12 Production and Modulate Rapid Differentiation of Human Monocytes into CD83+ Dendritic Cells
J. Immunol., February 15, 2005; 174(4): 2061 - 2070.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. C. Birchenall-Roberts, T. Fu, O.-s. Bang, M. Dambach, J. H. Resau, C. L. Sadowski, D. C. Bertolette, H.-J. Lee, S.-J. Kim, and F. W. Ruscetti
Tuberous Sclerosis Complex 2 Gene Product Interacts with Human SMAD Proteins: A MOLECULAR LINK OF TWO TUMOR SUPPRESSOR PATHWAYS
J. Biol. Chem., June 11, 2004; 279(24): 25605 - 25613.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z. Duan and M. Horwitz
Targets of the transcriptional repressor oncoprotein Gfi-1
PNAS, May 13, 2003; 100(10): 5932 - 5937.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020